Thomas L Harrison's Net Worth
$27.2 Million
Who is Thomas L Harrison?
Thomas L Harrison has an estimated net worth of $27.2 Million. This is based on reported shares across multiple companies, which include Morgans Hotel Group Co., RVUE HOLDINGS, INC., AFC Gamma, Inc., Fifth Street Asset Management Inc., Dipexium Pharmaceuticals, Inc., Acurx Pharmaceuticals, Inc., Zynerba Pharmaceuticals, Inc., EPOCRATES INC, OMNICOM GROUP INC, and AGENUS INC.
SEC CIK
Thomas L Harrison's CIK is 0001247340
Past Insider Trading and Trends
2017 was Thomas L Harrison's most active year for acquiring shares with 8 total transactions. Thomas L Harrison's most active month to acquire stocks was the month of April. 2007 was Thomas L Harrison's most active year for disposing of shares, totalling 12 transactions. Thomas L Harrison's most active month to dispose stocks was the month of October. 2007 saw Thomas L Harrison paying a total of $1,280,628.00 for 72,500 shares, this is the most they've acquired in one year. In 2007 Thomas L Harrison cashed out on 120,000 shares for a total of $3,020,615.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Morgans Hotel Group Co. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.54% | 10.82K |
—
|
—
| 41.27K |
May 17
| |||
Form 4
| +24.77% | 6.04K |
—
|
—
| 30.45K |
May 19
| |||
Form 4
| +51.59% | 8.3K |
—
|
—
| 24.4K |
May 20
| |||
Form 4
| +167.53% | 10.08K |
—
|
—
| 16.1K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
RVUE HOLDINGS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.5M |
$0.07 | $70,000.00 | 1.5M |
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AFC Gamma, Inc. (AFCG) Snapshot price: $10.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.02% | 1.28K |
$11.70 | $14,999.40 | 17.27K |
Jan 24
| |||
Form 4
| +6.41% | 963 |
$15.57 | $14,993.91 | 15.99K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| +49.86% | 5K |
$19.00 | $95,000.00 | 15.03K |
Mar 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Fifth Street Asset Management Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.00K |
$4.05 | -$24,300.00 |
0
|
Dec 8
| |||
Form 4/A
|
—
|
0
|
$3.68 | -$15,778.00 | 6K |
Nov 30
| |||
Form 4
|
—
|
0
|
$3.68 | -$15,778.00 |
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
∞
| 6K |
$17.00 | $102,000.00 | 6K |
Nov 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Dipexium Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +1.36% | 2K |
$12.00 | $24,000.00 | 148.83K |
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |